Hart & Patterson Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$609K Sell
789
-13
-2% -$10.8K 0.3% 47
2024
Q3
$711K Buy
802
+123
+18% +$111K 0.34% 46
2024
Q2
$615K Buy
679
+13
+2% +$10.4K 0.3% 45
2024
Q1
$518K Sell
666
-77
-10% -$54.8K 0.26% 47
2023
Q4
$433K Buy
+743
New +$434K 0.22% 44

Other funds holding LLY

Hart & Patterson Financial Group's LLY Position: Q4 2024 in Review

Hart & Patterson Financial Group reduced its Eli Lilly (LLY) stake by 1.6% in Q4 2024, selling an estimated $10.8K and leaving 789 shares worth $609K. The position accounts for 0.3% of the portfolio, ranked #47.

Hart & Patterson Financial Group first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. The position peaked at $711K in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Hart & Patterson Financial Group held 789 shares of Eli Lilly worth $609K as of Q4 2024.
  • Hart & Patterson Financial Group sold 13 Eli Lilly shares in Q4 2024, an estimated $10.8K.
  • Eli Lilly made up 0.3% of Hart & Patterson Financial Group's portfolio in Q4 2024, its #47 holding.
  • Hart & Patterson Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
  • Hart & Patterson Financial Group's Eli Lilly position peaked at $711K in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Hart & Patterson Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.